No hay tiempo para desmontajes (produccin crtica)
What Happens If You Miss a Dose of Semaglutide (Wegovy)
a
Europe: The Second-Largest Market Europe held the second-largest share of 23% in 2025 and is expected to grow at a notable CAGR of 13.1% during the projection period, driven mainly by expanding reimbursement and treatment access
Pricing, dosing, program length, medication availability, pharmacy preparation, and treatment recommendations may vary based on individual medical evaluation, provider assessment, treatment goals, and clinical appropriateness
Acknowledgements The authors would like to thank the patients who participated, the investigators, all trial site staff and all Novo Nordisk employees involved in these trials